Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
665
-
Total 13F shares, excl. options
-
46.7M
-
Shares change
-
-697K
-
Total reported value, excl. options
-
$19.3B
-
Value change
-
-$271M
-
Put/Call ratio
-
0.8
-
Number of buys
-
309
-
Number of sells
-
-281
-
Price
-
$412.67
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q3 2021
730 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q3 2021.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 665 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.7M shares
of 50.5M outstanding shares and own 92.57% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.92M shares), BlackRock Inc. (5.09M shares), FMR LLC (2.82M shares), STATE STREET CORP (1.96M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1.48M shares), Invesco Ltd. (1.47M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1.36M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (943K shares), GEODE CAPITAL MANAGEMENT, LLC (911K shares), and ROYAL BANK OF CANADA (719K shares).
This table shows the top 665 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.